25Aug
29Jul
Recent Study Confirms Medical Findings on Effectiveness of Sustained Acoustic Medicine in Soft Tissue Healing and Recovery
According to a recently published review of medical research, sustained acoustic medicine (SAM) delivered by the sam® device from Zetroz Systems is effective in soft-tissue injury healing, restoring function in patients, and helping them return to work or other normal daily activities. Read more >>
19Jul
ZetrOZ Systems Shares Successful Strategies for Managing a Robust Intellectual Property Portfolio
Running a successful medical device company requires deep knowledge of complex and specialized technologies, how to navigate regulatory requirements, and a thoughtful intellectual property (IP) protection strategy. ZetrOZ Systems' Dr. George Lewis, inventor of the sam® soft tissue healing pain relief ultrasound device, shares insights on how effective IP portfolio management can improve organizational efficiency that creates a competitive edge in today's health technology industry. Read more >>
29Jun
ZetrOZ Shares Insights for Providers and Patients Seeking Insurance Coverage on Novel Medical Technologies for Advanced Treatments
New medical technologies bring better outcomes to patients and more efficiency to the U.S. healthcare industry, but some insurers and care providers slow its adoption, according to ZetrOZ Systems, a leading innovator and inventor of sustained acoustic medicine for soft tissue injury healing. With more than 100,000 patients treated, George K. Lewis, Ph.D. and CEO of ZetrOZ Systems said, ZetrOZ has learned that a key to winning insurance provider approval of novel medical devices and therapies is thorough advance communication...
12May
US Veterans and Injured Workers Find Injury Solution With sam® Sustained Acoustic Medicine Treatment
Sustained acoustic medicine, or sam®, is a non-invasive ultrasound device from ZetrOZ Systems used to treat soft tissue injuries and arthritis. The U.S. Federal Drug Administration cleared sam® for clinical use in 2013, but many health care providers are just now discovering the many benefits it provides to treatment and recovery efforts. The sam® pain relief device has helped thousands of patients, including U.S. Veterans and Active Duty Members, regain mobility and reduce pain from common overuse injuries and osteoarthritis....
22Apr
ZetrOZ Meets Demand for sam® Wearable Ultrasound Soft Tissue Healing Device With Process Assessment and U.S. Manufacturing
As businesses return to normal operations with much more limited staffing, they can also expect to see workplace injuries increase, requiring employees to get specialized medical treatments or devices - which may be delayed or unavailable due to peaking supply chain logjams and regulatory challenges. ZetrOZ Systems, makers of the sustained acoustic medicine sam® device, is prepared to meet patients' needs through careful advanced planning and multi-site U.S. manufacturing. ZetrOZ's sam® is the only FDA-cleared, long-duration, home-use, ultrasound device to...
17Feb
New 372 Patient Study Finds That Common Soft-Tissue and Joint Injuries Are Treatable With SAM
A new research article on the last decade of clinical research concluded that sam®, the sustained acoustic medicine device from ZetrOZ Systems, is highly effective at healing tissue and reducing pain. The FDA-cleared sam® product family is a wearable, soft-tissue repairing and pain relief ultrasound device. It uses low-intensity, long-duration ultrasound at 3 MHz (above the audible range people can hear) to promote better patient outcomes than traditional ultrasound therapy applied in the clinical setting. By inhibiting inflammation and increasing...
28Jan
ZetrOZ Systems’ Sustained Acoustic Medicine Treatment Showcased at Big Sky Athletic Training Sports Medicine Conference
ZetrOZ Systems will showcase new clinical research on its Sustained Acoustic Medicine (sam®) wearable ultrasound device at the 2022 Big Sky Athletic Training Sports Medicine Conference on Monday, January 31, in Bozeman, Montana. In a session titled "New Approaches in Mechanobiology: Sustained Acoustic Medicine," Dr. George Lewis, founder and CEO of ZetrOZ Systems, will discuss the evolving field of low-intensity, long-duration ultrasound therapy, recent clinical outcomes, and a new systematic review and meta-analysis on the medical technology. Read more >>
14Jan
ZetrOZ Signs 5-Year Agreement With US Government to Supply Employees and Military With SAM Technology
ZetrOZ Systems has recently signed a 5-Year Healthcare Federal Supply Schedule Agreement to provide U.S. government healthcare institutes with its sustained acoustic medicine (sam®) device and hypoallergenic ultrasound coupling patches. The $3.4 million contract covers military bases and hospitals, veteran healthcare hospitals, and employees of the FBI, CIA, DOL, postal service, and other U.S. departments and agencies operating both in the United States and abroad. "We're proud to play our part in getting and keeping our federal employees healthy and...
30Dec